1
|
Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.
|
N Engl J Med
|
2004
|
3.44
|
2
|
Myostatin activation in patients with advanced heart failure and after mechanical unloading.
|
Eur J Heart Fail
|
2010
|
2.40
|
3
|
Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
|
J Card Surg
|
2010
|
2.25
|
4
|
Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure.
|
J Heart Lung Transplant
|
2008
|
1.46
|
5
|
Outcomes of cardiac transplantation in septuagenarians.
|
J Heart Lung Transplant
|
2012
|
1.40
|
6
|
Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery.
|
J Heart Lung Transplant
|
2005
|
1.10
|
7
|
Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support.
|
J Card Fail
|
2012
|
0.96
|
8
|
A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise.
|
J Card Fail
|
2009
|
0.94
|
9
|
Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study.
|
J Heart Lung Transplant
|
2013
|
0.90
|
10
|
Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.
|
J Heart Lung Transplant
|
2006
|
0.88
|
11
|
Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure.
|
J Heart Lung Transplant
|
2005
|
0.86
|
12
|
Myostatin is elevated in congenital heart disease and after mechanical unloading.
|
PLoS One
|
2011
|
0.85
|
13
|
A structured 3-step approach to evaluate cardiac recovery with continuous flow circulatory support.
|
J Heart Lung Transplant
|
2010
|
0.85
|
14
|
Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trial.
|
J Card Fail
|
2012
|
0.82
|
15
|
Ventricular assist devices as a bridge to transplant or recovery.
|
Cardiology
|
2004
|
0.80
|
16
|
Rheumatoid leptomeningitis after heart transplantation.
|
Neurology
|
2006
|
0.80
|
17
|
Cardiac recovery during continuous-flow left ventricular assist device support: some good news from across the Atlantic.
|
Circulation
|
2011
|
0.80
|
18
|
Impact of adverse events on ventricular assist device outcomes.
|
Curr Heart Fail Rep
|
2013
|
0.80
|
19
|
Improved exercise performance and skeletal muscle strength after simulated altitude exposure: a novel approach for patients with chronic heart failure.
|
J Card Fail
|
2012
|
0.79
|
20
|
Discontinuing antiresorptive therapy one year after cardiac transplantation: effect on bone density and bone turnover.
|
Transplantation
|
2006
|
0.77
|
21
|
Examination of explanted heart after radiofrequency ablation for intractable ventricular arrhythmia.
|
Circ Arrhythm Electrophysiol
|
2012
|
0.75
|
22
|
Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home.
|
J Heart Lung Transplant
|
2003
|
0.75
|